Showing results (11-20 of 67) with videos related to
Sort By:
Pageof 7
Oncotargets and Therapy|February 2, 2019
Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignanciesFiona H Tan, Tracy L Putoczki, Stanley S Stylli, et al.Cells|March 12, 2025
The Role of TIM-3 in Glioblastoma ProgressionFarah Ahmady, Amit Sharma, Adrian A Achuthan, et al.Current Drug Targets|November 21, 2014
The role of STAT3 signaling in mediating tumor resistance to cancer therapyFiona H Tan, Tracy L Putoczki, Stanley S Stylli, et al.Biophysical Journal|January 15, 2022
Cortical tension initiates the positive feedback loop between cadherin and F-actinQilin Yu, William R Holmes, Jean P Thiery, et al.Growth Factors (Chur, Switzerland)|May 12, 2012
Dynamin II function is required for EGF-mediated Stat3 activation but not Erk1/2 phosphorylationRodney B Luwor, Xiaowen Chin, Andrew B McGeachie, et al.Neoplasia (New York, N.Y.)|December 26, 2024
Systemic brain dissemination of glioblastoma requires transdifferentiation into endothelial-like cells via TGF-β-ALK1-Smad1/5 signalingThomas M B Ware, Adilson Fonseca Teixeira, Josephine Iaria, et al.BMC Cancer|July 9, 2016
Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancerChantel Samardzija, Rodney B Luwor, Michael A Quinn, et al.Molecular and Cellular Endocrinology|January 16, 2017
STAT3 signaling mediates tumour resistance to EGFR targeted therapeuticsAhmad A Zulkifli, Fiona H Tan, Tracy L Putoczki, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 21, 2015
Mouse models of gliomaStanley S Stylli, Rodney B Luwor, Thomas M B Ware, et al.Molecular Cancer|August 12, 2015
A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancerChantel Samardzija, Rodney B Luwor, Mila Volchek, et al.Pageof 7